These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 30592148)
21. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse. Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594 [TBL] [Abstract][Full Text] [Related]
22. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. Ingram LM; Finnerty MC; Mansoura M; Chou CW; Cummings BS Lipids Health Dis; 2021 Feb; 20(1):15. PubMed ID: 33596934 [TBL] [Abstract][Full Text] [Related]
23. Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers. Mengual L; Ars E; Lozano JJ; Burset M; Izquierdo L; Ingelmo-Torres M; Gaya JM; Algaba F; Villavicencio H; Ribal MJ; Alcaraz A Actas Urol Esp; 2014 Apr; 38(3):143-9. PubMed ID: 24206626 [TBL] [Abstract][Full Text] [Related]
24. Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines. Biancolella M; Valentini A; Minella D; Vecchione L; D'Amico F; Chillemi G; Gravina P; Bueno S; Prosperini G; Desideri A; Federici G; Bernardini S; Novelli G Invest New Drugs; 2007 Oct; 25(5):491-7. PubMed ID: 17636412 [TBL] [Abstract][Full Text] [Related]
25. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517 [TBL] [Abstract][Full Text] [Related]
26. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related]
27. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors. Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155 [TBL] [Abstract][Full Text] [Related]
28. Expression profile-based screening for critical genes reveals S100A4, ACKR3 and CDH1 in docetaxel-resistant prostate cancer cells. Zhu S; Min Z; Qiao X; Chen S; Yang J; Zhang X; Liu X; Ran W; Lv R; Lin Y; Wang J Aging (Albany NY); 2019 Dec; 11(24):12754-12772. PubMed ID: 31895690 [TBL] [Abstract][Full Text] [Related]
29. Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts. Wu L; Birle DC; Tannock IF Cancer Res; 2005 Apr; 65(7):2825-31. PubMed ID: 15805283 [TBL] [Abstract][Full Text] [Related]
30. Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. Benelli R; Barboro P; Costa D; Astigiano S; Barbieri O; Capaia M; Poggi A; Ferrari N Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816863 [TBL] [Abstract][Full Text] [Related]
31. Prostate cancer small non-coding RNA transcriptome in Arabs. Shan J; Al-Rumaihi K; Chouchane K; Al-Bozom I; Rabah D; Farhat K; Chouchane L J Transl Med; 2017 Dec; 15(1):260. PubMed ID: 29268752 [TBL] [Abstract][Full Text] [Related]
32. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis. Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230 [TBL] [Abstract][Full Text] [Related]
33. Analysis of Transcriptome, Selected Intracellular Signaling Pathways, Proliferation and Apoptosis of LNCaP Cells Exposed to High Leptin Concentrations. Szyszka M; Paschke L; Tyczewska M; Jopek K; Celichowski P; Milecka P; Sultanova G; Stelcer E; Malinska A; Malendowicz LK; Rucinski M Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671654 [TBL] [Abstract][Full Text] [Related]
34. Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway. Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304 [TBL] [Abstract][Full Text] [Related]
35. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b. Lin H; Shen Z; Liu H; Yang M; Lin J; Luo L; Liu L; Chen H Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):76-84. PubMed ID: 31531888 [TBL] [Abstract][Full Text] [Related]
37. In vivo passage of human prostate cancer cells in mice results in stable gene expression changes affecting numerous cancer-associated biological processes. Sivanathan L; Chow A; Wong A; Hoang VC; Emmenegger U Prostate; 2014 May; 74(5):537-46. PubMed ID: 24435653 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade. Adler D; Lindstrot A; Langer B; Buettner R; Wernert N Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114 [TBL] [Abstract][Full Text] [Related]
39. Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression. Oudes AJ; Roach JC; Walashek LS; Eichner LJ; True LD; Vessella RL; Liu AY BMC Cancer; 2005 Jul; 5():86. PubMed ID: 16042785 [TBL] [Abstract][Full Text] [Related]
40. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia. Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]